You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoid Tissue

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

The Lymphoid Tissue Pharmacology of Antiretroviral Drugs

Not yet recruiting
  • HIV Infection
  • Anti-HIV Agents
  • (no location specified)
Nov 4, 2022

HIV Infection Trial in New York (Colonoscopy)

Not yet recruiting
  • HIV Infection
  • Colonoscopy
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Dec 7, 2022

Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Ann Arbor Stage II Extranodal Marginal

Completed
Has Results
  • Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
  • +2 more
  • Radiation Therapy
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

HIV-1-infection, ART, Cd4+ Lymphocyte Deficiency Trial in Minneapolis (FT538, Vorinostat)

Not yet recruiting
  • HIV-1-infection
  • +4 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Jan 31, 2023

Adult Soft Tissue Sarcoma, Non Small Cell Lung Cancer, Triple Negative Breast Cancer Trial in France (Ezabenlimab + BI907828)

Not yet recruiting
  • Adult Soft Tissue Sarcoma
  • +4 more
  • Ezabenlimab + BI907828
  • Bordeaux, France
  • +5 more
Oct 19, 2023

Human Blood Cell Disorders Tissue Bank

Recruiting
  • Human Blood Cell Disorders
  • Lymphoid, Myeloid and Erythroid Proliferative Disease
    • Manhasset, New York
      The Feinstein Institute for Medical Research
    Jul 6, 2022

    Colon Cancer, Rectal Cancer Trial in Brooklyn (Lymphoseek and VBD Sln dissection)

    Completed
    Has Results
    • Colon Cancer
    • Rectal Cancer
    • Lymphoseek and VBD Sln dissection
    • Brooklyn, New York
      Maimonides medical Center
    Jun 22, 2021

    Cancer Trial in Villejuif (Pembrolizumab, Pembrolizumab and Olaparib, Pembrolizumab adjuvant)

    Not yet recruiting
    • Cancer
    • Villejuif, Val De Marne, France
      Gustave Roussy
    Oct 30, 2023

    Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma Trial in Milano (intralesional rituximab, supplemental autologous

    Completed
    • Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma
    • intralesional rituximab
    • supplemental autologous serum
    • Milano, Italy
      Dip. Oncoematologia - Fondazione Centro San Raffaele del Monte T
    Aug 2, 2022

    Viral Load in Blood and Lymph Tissues of HIV-Infected

    Recruiting
    • HIV
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 21, 2023

      Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Trial in Houston (Radiation Therapy)

      Recruiting
      • Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
      • Radiation Therapy
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 9, 2021

      Tumor Tissue Samples From Young Acute Lymphoblastic Leukemia

      Completed
      • Childhood Acute Lymphoblastic Leukemia in Remission
      • Recurrent Childhood Acute Lymphoblastic Leukemia
      • Laboratory Biomarker Analysis
      • Philadelphia, Pennsylvania
        Childrens Oncology Group
      Aug 12, 2022

      Collecting Blood and Tissue Sample Donations for Research for

      Not yet recruiting
      • Anal Carcinoma
      • +11 more
      • Biospecimen Collection
      • (no location specified)
      Dec 21, 2022

      Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,

      Suspended
      • Recurrent B-Cell Non-Hodgkin Lymphoma
      • +23 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Feb 23, 2022

      Hematopoietic and Lymphoid Cell Tumor, Steroid Refractory GVHD Trial in Houston (Cellular Therapy, Ruxolitinib)

      Recruiting
      • Hematopoietic and Lymphoid Cell Neoplasm
      • Steroid Refractory Graft Versus Host Disease
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 9, 2022

      Leukemia, Lymphoma Trial in Shijiazhuang (biological, drug, procedure)

      Recruiting
      • Leukemia
      • Lymphoma
      • Auto CAR-T
      • +2 more
      • Shijiazhuang, Hebei, China
        Pediatric hematology, Hebei Medical University Fourth Hospital
      Oct 29, 2020

      Mantle Cell Lymphoma, Follicular Lymphoma, Splenic Marginal Zone Lymphoma Trial in Chapel Hill (CAR.k.28, Fludarabine,

      Recruiting
      • Mantle Cell Lymphoma
      • +5 more
      • Chapel Hill, North Carolina
        Lineberger Comprehensive Cancer Center at University of North Ca
      Nov 19, 2021

      HIV Trial in United States (Zidovudine, Didanosine)

      Completed
      • HIV Infections
      • Palo Alto, California
      • +7 more
      Oct 28, 2021

      Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Extranodal Marginal Zone Lymphoma of

      Active, not recruiting
      • Recurrent B-Cell Non-Hodgkin Lymphoma
      • +22 more
      • Scottsdale, Arizona
      • +1 more
      Aug 10, 2021

      MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Atlanta, Columbus (drug, biological,

      Completed
      • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
      • +8 more
      • PI3K inhibitor BKM120
      • +3 more
      • Atlanta, Georgia
      • +1 more
      Jun 27, 2022

      Follicular Lymphoma, Diffuse Large B Cell Lymphoma, Marginal Zone Lymphoma Trial in France (Atezolizumab, Obinutuzumab,

      Completed
      • Follicular Lymphoma
      • +3 more
      • Angers, France
      • +24 more
      Jan 9, 2023

      MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Columbus (drug, biological,

      Active, not recruiting
      • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
      • +9 more
      • BTK inhibitor PCI-32765
      • +5 more
      • Columbus, Ohio
        Ohio State University Medical Center
      Jun 27, 2022

      Ex Vivo Drug Sensitivity Testing and Mutation Profiling

      Completed
      • Recurrent Childhood Acute Myeloid Leukemia
      • +13 more
        • Miami, Florida
          Nicklaus Children's Hospital
        Jan 18, 2023

        Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

        Recruiting
        • Recurrent Childhood Acute Myeloid Leukemia
        • +17 more
          • Miami, Florida
            Nicklaus Children's Hospital
          May 13, 2023

          Non-Hodgkin's Lymphoma, Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Ann Arbor

          Recruiting
          • Non-Hodgkin's Lymphoma
          • +18 more
          • Philadelphia, Pennsylvania
            Sidney Kimmel Cancer Center at Thomas Jefferson University
          Mar 11, 2021